Tuesday, February 7, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor of Respiratory Medicine
University Hospital
Basel, Switzerland
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Non-US Physicians - maximum of 1.00 CPD
This educational activity is intended for an international audience of non-US physicians, specifically primary care physicians and pulmonologists.
The goal of this activity is that learners will be better able to improve early recognition of exacerbations of chronic obstructive pulmonary disease (COPD) and optimize therapy with the goal of improving patient outcomes.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor of Respiratory Medicine
University Hospital
Basel, Switzerland
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim
credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online
during the credit
eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied
in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well
as the certificates by
accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 5/17/2022
Valid for credit through: 5/17/2023
processing....
The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.
 |
Martina is an overweight 55-year-old woman who presents to her family medicine office for a routine visit, during which she reports some dyspnea (ie, shortness of breath). She mentions that she has had a mild cough for some time, which is worse in the morning and sometimes produces grey sputum. She never required antibiotics or oral steroids.
Martina partially attributes her symptoms to her work at a hair salon as a stylist and colorist. She says her salon has poor ventilation and some of her coworkers smoke. Martina has a 30-pack-per-year history of smoking, which she stopped several years earlier after she developed trouble climbing the 3 flights of stairs to get to her apartment. She lives with her husband and 16-year-old son, neither of whom smoke. Martina confirms that her only comorbid condition is arterial hypertension but says there is a history of asthma in her family. Martina’s medical history includes chronic obstructive pulmonary disease (COPD), which is being treated with a long-acting muscarinic antagonist (LAMA), and hypertension, which is well controlled with an angiotensin-converting enzyme (ACE) inhibitor. She says she does not have any allergies.
